Success Stories: EB-1A Approved for a Postdoctoral Fellow in California in the Field of Nanomedicine
Client’s Testimonial:
Thanks again for the splendid job on my application. I have already referred you to some of my colleagues and some of them have already started working with you. I would be happy to recommend you on Linkedin as well.
On February 27th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Nanomedicine (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: February 27th, 2015
Processing Time: 28 days (4 days after Requesting Premium Processing)
For this case we worked with a nanomedical researcher from India with a specialized focus on targeted anticancer drug delivery, as well as the underlying mechanisms for drug resistance in cancer. His highly prolific career thus far had produced 10 peer-reviewed scientific articles, one book chapter, and numerous presentations at national and international conferences, and he had been cited at least 690 times, primarily by independent researchers at prominent and leading institutions and organizations worldwide. This remarkable citation record clearly indicates the major significance of our client’s work. He had also reviewed at least 15 manuscripts for 6 or more distinctive, internationally-circulated journals. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Nanomedicine, and that his continued research would substantially and prospectively benefit the United States. An independent recommender affirmed the significance of our client’s research: “The aforementioned paper discusses a groundbreaking approach to cancer therapy…While conventional cancer therapies can often alter tumor growth, patients tend to become resistant to chemotherapeutic medicines, making it difficult for doctors to completely destroy all malignant cells in order to achieve full remission. [Client’s] work is essential in doctors' efforts to develop superior cancer therapies.” With the proof and documentation that we provided, his case was approved in 28 days (4 days after requesting Premium Processing)